Decision: Unfavourable

Study Title:

CONNected Electronic Inhalers Asthma Control Trial 3 (“CONNECT 3”), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optim

  • NREC Code:

    22-NREC-CT-028

  • Decision:

    Unfavourable

  • Study Type:

    NREC CT B

  • Principal Investigator:

    Dr Richard Costello

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Teva Branded Pharmaceutical Products R&D, Inc.

Scroll to Top
Skip to content